Cargando…
Novel germline MSH2 mutation in lynch syndrome patient surviving multiple cancers
Lynch syndrome (LS) individuals are predisposed to a variety of cancers, most commonly colorectal, uterine, urinary tract, ovarian, small bowel, stomach and biliary tract cancers. The risk of extracolonic manifestations appears to be highest in MSH2 mutations carriers. We present a carrier case with...
Autores principales: | Janavicius, Ramunas, Elsakov, Pavel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3275504/ https://www.ncbi.nlm.nih.gov/pubmed/22234272 http://dx.doi.org/10.1186/1897-4287-10-1 |
Ejemplares similares
-
A Novel Mutation of MSH2 Gene in a Patient with Lynch Syndrome Presenting with Thirteen Metachronous Malignancies
por: Silinskaite, Ugne, et al.
Publicado: (2023) -
Novel MSH2 Mutation in the First Report of a Vietnamese–American Kindred with Lynch Syndrome
por: Eskander, Ramez N., et al.
Publicado: (2015) -
An MSH6 germline pathogenic variant p.Gly162Ter associated with Lynch syndrome
por: Vostrukhina, Olga A., et al.
Publicado: (2022) -
A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome
por: Rashid, Muhammad U., et al.
Publicado: (2016) -
Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report
por: Takeda, Takashi, et al.
Publicado: (2018)